Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target

1 Feb 2020

Abstract excerpt

Emerging evidence has provided important information on oncoproteins involved in cancer initiation, progression, metastasis, and resistance to current therapies. C-myc, one of the critical oncoproteins, has been shown to be implicated in enhancing the aggressiveness of many cancers, mainly through its ability to increase cancer cell growth and cellular survival mechanisms. Despite the more precise and earlier...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32014901
DOI: 10.21873/anticanres.13990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug TargetPMID 32014901Read ↗

Lung cancer and metastasis: new opportunities and challenges.Semantic proximity Read ↗

Lung Adenocarcinoma Tumor Origin: A Guide for Personalized MedicineSemantic proximity Read ↗

Oncogenic driver mutations in lung cancerSemantic proximity Read ↗

Novel insights into the molecular origins and treatment of lung cancer.Semantic proximity Read ↗

The molecular pathogenesis of small cell lung cancerSemantic proximity Read ↗

Signal pathways and precision therapy of small-cell lung cancerSemantic proximity Read ↗

[Molecular pathogenesis of lung cancer].Semantic proximity Read ↗

Established, emerging and elusive molecular targets in the treatment of lung cancer.Semantic proximity Read ↗

Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer ProgressionSemantic proximity Read ↗

Taking on challenging targets: making MYC druggable.Semantic proximity Read ↗

Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations.Semantic proximity Read ↗

myc genes and their deregulation in lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.